BioCentury
ARTICLE | Clinical News

Pharmasset starts Racivir Phase II

November 10, 2004 8:00 AM UTC

Pharmasset (Tucker, Ga.) began the placebo-controlled, international Phase II RCV-201 trial of Racivir in 60 HIV patients. The trial, which is enrolling patients who have been receiving Epivir for 60 ...